These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 32736693)

  • 1. BCCIPβ facilitates p53 ubiquitination via binding with E6 protein in high-risk HPV positive head and neck squamous cell carcinoma.
    Wang F; Wang J; Wang J; Zhang L; Fu H; Li J; Tian T; Zuo J; Lv W; Ma X
    Biochem Biophys Res Commun; 2020 Aug; 529(3):685-691. PubMed ID: 32736693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest.
    Li C; Johnson DE
    Cell Cycle; 2013 Mar; 12(6):923-34. PubMed ID: 23421999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.
    Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
    Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
    Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line.
    Harris M; Wang XG; Jiang Z; Goldberg GL; Casadevall A; Dadachova E
    Head Neck Oncol; 2011 Feb; 3(1):9. PubMed ID: 21314983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.
    Masterson L; Winder DM; Ball SL; Vaughan K; Lehmann M; Scholtz LU; Sterling JC; Sudhoff HH; Goon PK
    BMC Cancer; 2016 Jun; 16():367. PubMed ID: 27296171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma.
    Xie X; Piao L; Bullock BN; Smith A; Su T; Zhang M; Teknos TN; Arora PS; Pan Q
    Oncogene; 2014 Feb; 33(8):1037-46. PubMed ID: 23474763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic E6 and/or E7 proteins drive proliferation and invasion of human papilloma virus‑positive head and neck squamous cell cancer through upregulation of Ror2 expression.
    Avincsal MO; Kamizaki K; Jimbo N; Shinomiya H; Nibu KI; Nishita M; Minami Y
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR-induced suppression of HPV E6/E7 is mediated by microRNA-9-5p silencing of BRD4 protein in HPV-positive head and neck squamous cell carcinoma.
    Nantajit D; Presta L; Sauter T; Tavassoli M
    Cell Death Dis; 2022 Nov; 13(11):921. PubMed ID: 36333293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of HPV16/18 E6 Oncoproteins in Head and Neck Squamous Cell Carcinoma Using a Protein Immunochromatographic Assay.
    Menegaldo A; Schroeder L; Holzinger D; Tirelli G; Dal Cin E; Tofanelli M; Rigo S; Mantovani M; Stellin M; Del Mistro A; Dei Tos AP; Guerriero A; Niero M; Borsetto D; Da Mosto MC; Polesel J; Pawlita M; Waterboer T; Boscolo-Rizzo P
    Laryngoscope; 2021 May; 131(5):1042-1048. PubMed ID: 33103777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells.
    Kahue CN; Jerrell RJ; Parekh A
    Cancer Rep (Hoboken); 2018 Oct; 1(3):e1125. PubMed ID: 32721084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wild-type p53 reactivation by small-molecule Minnelide™ in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma.
    Caicedo-Granados E; Lin R; Fujisawa C; Yueh B; Sangwan V; Saluja A
    Oral Oncol; 2014 Dec; 50(12):1149-56. PubMed ID: 25311433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
    López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
    Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV16 E6 regulates annexin 1 (ANXA1) protein expression in cervical carcinoma cell lines.
    Calmon MF; Sichero L; Boccardo E; Villa LL; Rahal P
    Virology; 2016 Sep; 496():35-41. PubMed ID: 27240147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation.
    Alsahafi EN; Thavaraj S; Sarvestani N; Novoplansky O; Elkabets M; Ayaz B; Tavassoli M; Legends MF
    Cancer Lett; 2021 Feb; 498():80-97. PubMed ID: 33137407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus oncoprotein E6 upregulates c-Met through p53 downregulation.
    Qian G; Wang D; Magliocca KR; Hu Z; Nannapaneni S; Kim S; Chen Z; Sun SY; Shin DM; Saba NF; Chen ZG
    Eur J Cancer; 2016 Sep; 65():21-32. PubMed ID: 27451021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus.
    Smeets SJ; Braakhuis BJ; Abbas S; Snijders PJ; Ylstra B; van de Wiel MA; Meijer GA; Leemans CR; Brakenhoff RH
    Oncogene; 2006 Apr; 25(17):2558-64. PubMed ID: 16314836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention against head and neck cancer-containing HPV16 cell lines.
    Adhim Z; Otsuki N; Kitamoto J; Morishita N; Kawabata M; Shirakawa T; Nibu K
    Acta Otolaryngol; 2013 Jul; 133(7):761-71. PubMed ID: 23638950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E6 Protein Expressed by High-Risk HPV Activates Super-Enhancers of the
    Chen X; Loo JX; Shi X; Xiong W; Guo Y; Ke H; Yang M; Jiang Y; Xia S; Zhao M; Zhong S; He C; Fu L; Li F
    Cancer Res; 2018 Mar; 78(6):1418-1430. PubMed ID: 29339538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma.
    Carper MB; Troutman S; Wagner BL; Byrd KM; Selitsky SR; Parag-Sharma K; Henry EC; Li W; Parker JS; Montgomery SA; Cleveland JL; Williams SE; Kissil JL; Hayes DN; Amelio AL
    Cell Rep; 2019 Nov; 29(6):1660-1674.e7. PubMed ID: 31693903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.